Interleukin inhibitors for psoriatic arthritis

To evaluate benefits and harms of interleukin inhibitors for the treatment of psoriatic arthritis (PsA).

This is a protocol.

Health topics:

Rheumatology > Reactive arthritis

Published:

13 June 2018

Authors:

Sharma G, Mudano AS, Singh JA

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Sharma G, Mudano AS, Singh JA. Interleukin inhibitors for psoriatic arthritis. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD013043. DOI: 10.1002/14651858.CD013043